BBSI is a profitable, cash-generative PEO and staffing platform that sold off after Q2 2026 margin pressure. The setup is not a deep distress asymmetry; it is a factor-driven VALUE/QUALITY case where debt-free operating leverage, net cash, a funded buyback and improving workers' compensation pricing can support a recovery toward analyst targets if 2026 proves to be the margin trough.
The final FV implies about 12.0x FY2027E EBITDA before net cash and explicit reserves, within the peer range and about 9% below the closest PEO peer median. A plus/minus 2.0x move in the EBITDA multiple changes FV by about $6.44/sh, so the model is meaningfully sensitive to margin recovery. Not investment advice.
| Component | Assumption | USD/share |
|---|---|---|
| Core PEO/staffing EV | $78M FY2027E EBITDA x 12.0x EV/EBITDA / 24.24M shares | +38.61 |
| Net cash and investments | ($67.9M cash/investments - $24.5M debt/lease debt) / 24.24M shares | +1.79 |
| Expected buyback accretion | 50% probability x $40.3M remaining authorization / 24.24M shares | +0.83 |
| Tax-credit reserve | -$11.6M Q1 2026 tax-effected prior-year credit charge / 24.24M shares | -0.48 |
| Workers' compensation margin reserve | -$24.0M reserve for slower prior-year claims benefits and health-cost pressure / 24.24M shares | -0.99 |
| Technology platform option | 20% probability x $50M operating efficiency value from IT/product launches / 24.24M shares | +0.41 |
| Liquidity rounding | -$0.01/sh rounding to avoid false precision in a sub-$1B small-cap | -0.01 |
| FV base case | Exact sum: 38.61 + 1.79 + 0.83 - 0.48 - 0.99 + 0.41 - 0.01 = $40.16, rounded to $40.20 | 40.20 |
Insider check: MarketBeat reports about $5.39M of insider selling in the last 12 months, including Gary Kramer, CEO, selling about $3.87M on 2025-08-25, partly offset by his $225K open-market purchase on 2026-03-13. That mixed signal belongs in monitoring, but it is not paired with a current class-action or SEC-investigation finding in the searches performed.
| Item | FY2022 | FY2023 | FY2024 | FY2025 | TTM Jun-26 / FY26 guide |
|---|---|---|---|---|---|
| Revenue | $1.05B | $1.07B | $1.15B | $1.24B | $1.27B TTM |
| Revenue growth | +10.4% | +1.4% | +7.0% | +8.4% | +5.6% TTM |
| Operating income | $59.0M | $60.7M | $59.8M | $62.2M | $52.2M TTM |
| Net income | $47.3M | $50.6M | $53.0M | $54.4M | $35.1M TTM |
| EPS | $1.64 | $1.85 | $1.98 | $2.08 | $1.38 TTM; tax charge distorted H1 |
| Gross billings guidance | N/D | N/D | $8.33B | $9.04B | FY26 +3% to +4% |
| Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Revenue ($M) | 307.7 | 318.9 | 321.1 | 307.0 | 319.3 |
| Gross margin % | 23.8% | N/D | N/D | 14.1% | 20.3% |
| Net income / loss ($M) | 18.5 | 20.6 | 16.4 | -14.8 | 12.9 |
| Cash & investments EOP ($M) | N/D | 109.8 | 157.2 | 91.9 | 67.9 |
Business model - PEO plus staffing
Professional employer services ~$1.22B FY2026E revenue; >95% of net revenue ramping Core co-employment platform with payroll, tax, HR, workers' comp and benefits. Q2 2026 PEO revenue was $305.0M, up about 5.1% year over year. Staffing services ~$55-60M FY2026E revenue; low-single-digit mix cyclical Traditional staffing remains a smaller, more cyclical line. Q2 2026 staffing revenue was $14.3M versus $17.5M a year earlier. Technology and pricing actions Option value: ~$50M platform value x 20% probability to prove Management has discussed IT initiatives and sustained workers' compensation pricing actions. These are not yet credited as a full rerating until visible in 2027 margins.
Legal, regulatory and risk analysis
SWOT analysis
- +Debt-free operating profile with net cash.
- +PEO client base across all 50 states.
- +Active and material repurchase authorization.
- +Long operating history and positive normalized earnings.
- −First-half 2026 earnings were distorted downward.
- −Gross margin depends on claims and benefit cost development.
- −Staffing segment is cyclical and shrinking.
- −Small-cap liquidity limits institutional sponsorship.
- →Pricing actions can rebuild margin through 2027.
- →Buybacks below fair value can compound per-share value.
- →Q3/Q4 evidence of WSE recovery would support rerating.
- →Technology initiatives may improve service efficiency.
- !Claims inflation can offset pricing.
- !SMB slowdown can reduce billings and WSE growth.
- !Further analyst downgrades could cap multiple recovery.
- !Regulatory changes in payroll, tax or insurance markets can create cost shocks.
Summary by assessment area
- Cash and investments exceed debt/leases, and the company says it remained debt free at quarter end.
- The balance sheet can fund buybacks, dividends and ordinary operating volatility.
- The Q2 margin reset is real; 2027 recovery is the key valuation bridge.
- SMB hiring softness and claims-cost timing are the main variables to track.
- Base FV of $40.20 implies about 20% upside from the verified price line.
- The upside is credible, but not wide enough for an asymmetric label.
Sources: Yahoo Finance for the dedicated current-price check; MarketBeat, QuoTrend and StockAnalysis for price cross-check, market cap, 52-week range, shares, short interest, analyst targets and valuation ratios; BBSI Q2 2026 earnings release and SEC 10-Q for revenue, gross billings, cash, balance sheet, buyback and risk factors; Benzinga, MarketBeat and TipRanks snippets for latest analyst target changes dated 2026-08-06; SEC / BBSI Section 16 and MarketBeat for Form 4 insider activity; StockAnalysis for peer data on TNET, KFY and KFRC. Market data used: BBSI price ~$33.37 at market open on 2026-08-27; cross-checks include MarketBeat ~$33.78 and QuoTrend ~$33.80, within about 1.3%; market cap about $809M; 52-week range $25.33-$49.65; shares outstanding about 24.24M. This document is for informational purposes only and does not constitute financial or investment advice.